Quest Diagnostics Inc (N:DGX)

Business Focus: Healthcare Facilities & Services

Sector:  Healthcare Industry:  Healthcare Facilities & Services
 
See Regulatory Filings on SEC
Company Contact
Address: 500 Plaza Dr
SECAUCUS NJ 07094-3619
Tel: N/A
Website: https://www.questdiagnostics.com
IR: See website
<
Key People
Stephen H. Rusckowski
Chairman of the Board, President, Chief Executive Officer
Mark J. Guinan
Chief Financial Officer, Executive Vice President
James E. Davis
Executive Vice President, General Diagnostics
Michael E. Prevoznik
Senior Vice President, General Counsel
Catherine T. Doherty
Senior Vice President, Group Executive - Clinical Franchise Solutions and Marketing
Carrie Eglinton Manner
Senior Vice President - Advanced Diagnostics
Manuel O. Mendez
Executive Officer
   
Business Overview
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, Focus Diagnostics, Athena Diagnostics, ExamOne, Quanum and Care360.
Financial Overview
For the six months ended 30 June 2020, Quest Diagnostics Inc revenues decreased 5% to $3.65B. Net income applicable to common stockholders excluding extraordinary items decreased 23% to $283M. Revenues reflect DIS Business segment decrease of 5% to $3.51B, All other operating segments decrease of 12% to $141M. Net income also reflects DIS Business segment income decrease of 22% to $485M, All other operating segments income decrease of 38% to $13M.
Employees: 47,000 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $19,815M as of Jun 30, 2020
Annual revenue (TTM): $7,531M as of Jun 30, 2020
EBITDA (TTM): $1,533M as of Jun 30, 2020
Net annual income (TTM): $749.00M as of Jun 30, 2020
Free cash flow (TTM): $527.00M as of Jun 30, 2020
Net Debt Last Fiscal Year: $3,587M as of Jun 30, 2020
Shares outstanding: 134,302,631 as of Jul 15, 2020
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.